The Usefulness of Tubulin Beta 3 (TUBB3) in Distinguishing Reactive Follicular Hyperplasia From Follicular Lymphoma: Results from an Extended Series Including In Situ Follicular Lymphoma

被引：0
|
作者：
Zamo, Alberto [1 ]
Erdini, Francesco [1 ]
Chilosi, Marco [1 ]
机构：
[1] Univ Verona, I-37100 Verona, Italy
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1555
引用
收藏
页码：390A / 391A
页数：2
相关论文
共 50 条
  • [21] HLA-DO is a useful marker to distinguish florid follicular hyperplasia from follicular lymphoma by flow cytometry
    Li, S
    Chen, X
    Jensen, PE
    LABORATORY INVESTIGATION, 2003, 83 (01) : 242A - 242A
  • [22] ABERRANT MT2 POSITIVITY DISTINGUISHES FOLLICULAR LYMPHOMA FROM REACTIVE FOLLICULAR HYPERPLASIA IN B5-FIXED AND FORMALIN-FIXED PARAFFIN SECTIONS
    BROWNE, G
    TOBIN, B
    CARNEY, DN
    DERVAN, PA
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991, 96 (01) : 90 - 94
  • [23] Pediatric Follicular Lymphoma: A Report of the First 3 Cases From Taiwan and Literature Review
    Yang, Sheau-Fang
    Chuang, Wen-Yu
    Chang, Seng-Tsung
    Liu, Hongxiang
    Chen, Rong-Long
    Chuang, Shih-Sung
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2011, 28 (08) : 661 - 668
  • [24] Neoantigens in Patients with De Novo Follicular Lymphoma: Results from the PRIMA Study
    Henneges, Carsten
    Jin, Dexter X.
    Venstrom, Jeffrey M.
    Trabucco, Sally E.
    Nielsen, Tina G.
    Penuel, Elicia M.
    Huet, Sarah
    Salles, Gilles
    Paulson, Joseph N.
    BLOOD, 2020, 136
  • [25] Tafasitamab Plus Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma: Results from a Phase 3 Study (inMIND)
    Sehn, Laurie H.
    Luminari, Stefano
    Scholz, Christian W.
    Huebel, Kai
    Salar, Antonio
    Paneesha, Shankara
    Wahlin, Bjorn E.
    Panayiotidis, Panayiotis
    Lee, Hui-Peng
    Ubieto, Ana Jimenez
    Sancho, Juan-Manuel
    Kim, Tae Min
    Domenech, Eva Domingo
    Kumode, Takahiro
    Poh, Christina
    Thieblemont, Catherine
    Deeren, Dries
    de Wit, Edwin
    Arbushites, Michael
    Casadebaig, Marie-Laure
    Trneny, Marek
    BLOOD, 2024, 144 : LBA1 - LBA4
  • [26] Follicular lymphoma in young patients: Prognostic and survival data from the Stanford series.
    Lucas, JB
    Tisbsharini, R
    Brophy, N
    Horning, SJ
    BLOOD, 1999, 94 (10) : 516A - 516A
  • [27] Expanding the Morphologic Spectrum of Follicular Lymphoma In Situ: 13 Examples Including In Situ Grade 3 and BCL2-Negative Cases
    Bala, R.
    Warnke, R. A.
    Natkunam, Y.
    LABORATORY INVESTIGATION, 2012, 92 : 324A - 324A
  • [28] Expanding the Morphologic Spectrum of Follicular Lymphoma In Situ: 13 Examples Including In Situ Grade 3 and BCL2-Negative Cases
    Bala, R.
    Warnke, R. A.
    Natkunam, Y.
    MODERN PATHOLOGY, 2012, 25 : 324A - 324A
  • [29] Differential expression of estrogen receptor-α on follicular dendritic cells from patients with grade 1-2 and grade 3 follicular lymphoma
    Ohe, Rintaro
    Meng, Hong-Xue
    Aung, Naing Ye
    Yamada, Akane
    Kabasawa, Takanobu
    Utsunomiya, Aya
    Tamazawa, Nobuyuki
    Tamura, Yuka
    Kitaoka, Takumi
    Hashimoto, Toshio
    Shibata, Kenichi
    Toubai, Tomomi
    Kimura, Wataru
    Ishizawa, Kenichi
    Yamakawa, Mitsunori
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (02) : 151 - 159
  • [30] Follicular Lymphoma Grade 3A Is Different from Grade 1/2 in the Real World
    Li, Chunyuan
    Yang, Ping
    Wan, Wei
    Liu, Shuozi
    Jing, Hongmei
    BLOOD, 2021, 138
12345